<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>GEOCILLIN- carbenicillin indanyl sodium tablet, film coated </strong><br>Roerig<br></p></div>
<h1>GEOCILLIN®<br>
carbenicillin indanyl sodium<br>
TABLETS<br>
For Oral Use	</h1>
<div class="Contents">
<div class="Section">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-2"></a><p></p>
<h1></h1>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of Geocillin® and other antibacterial drugs, Geocillin should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-3"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Geocillin, a semisynthetic penicillin, is the sodium salt of the indanyl ester of Geopen® (carbenicillin disodium). The chemical name is: 1-(5-Indanyl)-N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] hept-6-yl)-2-phenylmalonamate monosodium salt.</p>
<p>The structural formula is:</p>
<div class="Figure"><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=02010995-9826-4A67-945B-F3022E6081DF&amp;name=geocillin-image01.jpg"></div>
<p>The empirical formula iis: C<span class="Sub">26</span>H<span class="Sub">25</span>N<span class="Sub">2</span>NaO<span class="Sub">6</span>S and mol. wt. is 516.55.</p>
<p>Geocillin tablets are yellow, capsule-shaped and film-coated, made of a white crystalline solid. Carbenicillin is freely soluble in water. Each Geocillin tablet contains 382 mg of carbenicillin, 118 mg of indanyl sodium ester. Each Geocillin tablet contains 23 mg of sodium.</p>
<p>Inert ingredients are: glycine; magnesium stearate and sodium lauryl sulfate. May also include the following: hydroxypropyl cellulose; hypromellose; opaspray (which may include Blue 2 Lake, Yellow 6 Lake, Yellow 10 Lake, and other inert ingredients); opadry light yellow (which may contain D&amp;C Yellow 10 Lake, FD&amp;C Yellow 6 Lake and other inert ingredients); opadry clear (which may contain other inert ingredients).</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-4"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Free carbenicillin is the predominant pharmacologically active fraction of Geocillin. Carbenicillin exerts its antibacterial activity by interference with final cell wall synthesis of susceptible bacteria.</p>
<p>Geocillin is acid stable, and rapidly absorbed from the small intestine following oral administration. It provides relatively low plasma concentrations of antibiotic and is primarily excreted in the urine. After absorption, Geocillin is rapidly converted to carbenicillin by hydrolysis of the ester linkage. Following ingestion of a single 500 mg tablet of Geocillin, a peak carbenicillin plasma concentration of approximately 6.5 mcg/ml is reached in 1 hour. About 30% of this dose is excreted in the urine unchanged within 12 hours, with another 6% excreted over the next 12 hours.</p>
<p>In a multiple dose study utilizing volunteers with normal renal function, the following mean urine and serum levels of carbenicillin were achieved:</p>
<table width="100%">
<col align="left" width="10%">
<col align="left" width="10%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<col align="center" width="8%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule" align="left"></td>
<td class="Botrule Lrule" align="left"></td>
<td class="Botrule Lrule Rrule" align="center" colspan="9">Mean Urine Concentration of  Carbenicillin mcg/ml Hours After Initial Dose</td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">DRUG</td>
<td class="Lrule" align="left">DOSE</td>
<td class="Lrule" align="center">0–3</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">3–6</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">6–24</td>
<td class="Lrule Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">Geocillin</td>
<td class="Lrule Toprule" align="left">1 tablet<br>
q.6 hr</td>
<td class="Lrule Toprule" align="center">1130</td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Toprule" align="center">352</td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Rrule" align="center"></td>
<td class="Lrule" align="center">292</td>
<td class="Lrule Rrule Toprule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">Geocillin</td>
<td class="Lrule" align="left">2 tablets<br>
q.6 hr</td>
<td class="Lrule" align="center">1428</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">789</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">809</td>
<td class="Lrule Rrule" align="center"></td>
</tr>
<tr class="Botrule"><td class="Lrule Rrule Toprule" align="left" colspan="11">Mean serum concentrations of carbenicillin in this study for these dosages are:</td></tr>
<tr class="Botrule">
<td class="Lrule Toprule" align="left"></td>
<td class="Lrule Toprule" align="left"></td>
<td class="Lrule Rrule Toprule" align="center" colspan="9">Mean Serum Concentration mcg/ml Hours After Initial Dose</td>
</tr>
<tr class="Botrule">
<td class="Botrule Lrule" align="left">DRUG</td>
<td class="Botrule Lrule" align="left">DOSE</td>
<td class="Lrule Toprule" align="center">1/2</td>
<td class="Lrule Toprule" align="center">1</td>
<td class="Lrule Toprule" align="center">2</td>
<td class="Lrule Toprule" align="center">4</td>
<td class="Lrule Toprule" align="center">6</td>
<td class="Lrule Toprule" align="center">24</td>
<td class="Lrule Toprule" align="center">25</td>
<td class="Lrule Toprule" align="center">26</td>
<td class="Lrule Rrule Toprule" align="center">28</td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">Geocillin</td>
<td class="Lrule Toprule" align="left">1 tablet<br>
q.6 hr</td>
<td class="Lrule Toprule" align="center">5.1</td>
<td class="Lrule Toprule" align="center">6.5</td>
<td class="Lrule Toprule" align="center">3.2</td>
<td class="Lrule Toprule" align="center">1.9</td>
<td class="Lrule Toprule" align="center">0.0</td>
<td class="Lrule Toprule" align="center">0.4</td>
<td class="Lrule Toprule" align="center">8.8</td>
<td class="Lrule Toprule" align="center">5.4</td>
<td class="Lrule Rrule Toprule" align="center">0.4</td>
</tr>
<tr class="Last">
<td class="Lrule" align="left">Geocillin</td>
<td class="Lrule Toprule" align="left">2 tablets<br>
q.6 hr</td>
<td class="Lrule Toprule" align="center">6.1</td>
<td class="Lrule Toprule" align="center">9.6</td>
<td class="Lrule Toprule" align="center">7.9</td>
<td class="Lrule Toprule" align="center">2.6</td>
<td class="Lrule Toprule" align="center">0.4</td>
<td class="Lrule Toprule" align="center">0.8</td>
<td class="Lrule Toprule" align="center">13.2</td>
<td class="Lrule Toprule" align="center">12.8</td>
<td class="Lrule Rrule" align="center">3.8</td>
</tr>
</tbody>
</table>
<div class="Section" data-sectionCode="49489-8">
<a name="section-4.1"></a><p></p>
<h2>Microbiology</h2>
<p class="First">The antibacterial activity of Geocillin is due to its rapid conversion to carbenicillin by hydrolysis after absorption. Though Geocillin provides substantial <span class="Italics">in vitro</span>
 activity against a variety of both gram-positive and gram-negative microorganisms, the most important aspect of its profile is in its antipseudomonal and antiproteal activity. Because of the high urine levels obtained following administration, Geocillin has demonstrated clinical efficacy in <span class="product-label-link" type="condition" conceptid="4056621" conceptname="Recurrent urinary tract infection">urinary infections</span> due to susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of:</p>
<p>  <span class="Italics">Escherichia coli<br>  Proteus mirabilis<br>  Proteus vulgaris<br>  Morganella morganii </span>
(formerly <span class="Italics">Proteus morganii</span>)<br>  <span class="Italics">Pseudomonas</span>
 species<br>    <span class="Italics">Providencia rettgeri</span>
 (formerly <span class="Italics">Proteus rettgeri</span>)<br>  <span class="Italics">Enterobacter</span>
 species<br>  Enterococci (<span class="Italics">S. faecalis</span>)</p>
<p>In addition, <span class="Italics">in vitro</span>
 data, not substantiated by clinical studies, indicate the following pathogens to be usually susceptible to Geocillin:</p>
<p>  <span class="Italics">Staphylococcus</span>
 species (nonpenicillinase producing)<br>  <span class="Italics">Streptococcus</span>
 species</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-4.2"></a><p></p>
<h2>Resistance</h2>
<p class="First">Most <span class="Italics">Klebsiella</span>
 species are usually resistant to the action of Geocillin. Some <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics">Pseudomonas</span>
 species have developed resistance to carbenicillin.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-4.3"></a><p></p>
<h2>Susceptibility Testing</h2>
<p class="First">Geopen (carbenicillin disodium) Susceptibility Powder or 100 µg Geopen Susceptibility Discs may be used to determine microbial susceptibility to Geocillin using one of the following standard methods recommended by the National Committee for Clinical Laboratory Standards:</p>
<p>M2-A3, "Performance Standards for Antimicrobial Disk Susceptibility Tests"</p>
<p>M7-A, "Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically"</p>
<p>M11-A, "Reference Agar Dilution Procedure for Antimicrobial Susceptibility Testing of Anaerobic Bacteria"</p>
<p>M17-P, "Alternative Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria"</p>
<p>Tests should be interpreted by the following criteria:</p>
<table width="75%">
<col align="left" width="20%">
<col align="center" width="10%">
<col align="center" width="10%">
<col align="center" width="10%">
<col align="center" width="10%">
<col align="center" width="10%">
<col align="center" width="10%">
<tbody class="Headless">
<tr class="Botrule First">
<td class="Lrule" align="left"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center" colspan="3">Disk Diffusion</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center" colspan="3">Zone diameter (mm)</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">Organisms</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">Suscept.</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">Intermed.</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center">Resist.</td>
</tr>
<tr class="Botrule">
<td class="Lrule Toprule" align="left"><span class="Italics">Enterobacter</span></td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Toprule" align="center">≥23</td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Toprule" align="center">18–22</td>
<td class="Lrule Toprule" align="center"></td>
<td class="Lrule Rrule Toprule" align="center">≤17</td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left">
<span class="Italics">Pseudomonas</span>
 sp.</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">≥17</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">14–16</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center">≤13</td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center" colspan="3">Dilution</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left"></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center" colspan="3">MIC (µg/ml)</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule" align="left" valign="bottom">Organisms</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center" valign="bottom">Suscept.</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center" valign="bottom">Moderately Suscept.</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center" valign="bottom">Resist.</td>
</tr>
<tr class="Botrule">
<td class="Lrule Toprule" align="left"><span class="Italics">Enterobacter</span></td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">≤16</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">32</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center">≥64</td>
</tr>
<tr class="Last">
<td class="Lrule" align="left">
<span class="Italics">Pseudomonas</span>
 sp.</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">≤128</td>
<td class="Lrule" align="center"></td>
<td class="Lrule" align="center">—</td>
<td class="Lrule" align="center"></td>
<td class="Lrule Rrule" align="center">≥156</td>
</tr>
</tbody>
</table>
<p>Interpretations of susceptible, intermediate, and resistant correlate zone size diameters with MIC values. A laboratory report of  "susceptible" indicates that the suspected causative microorganism most likely will respond to therapy with carbenicillin. A laboratory report of  "resistant" indicates that the infecting microorganism most likely will not respond to therapy. A laboratory report of "moderately susceptible" indicates that the microorganism is most likely susceptible if a high dosage of carbenicillin is used, or if the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> is such that high levels of carbenicillin may be attained as in urine. A report of "intermediate" using the disk diffusion method may be considered an equivocal result, and dilution tests may be indicated.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-5"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Geocillin (carbenicillin indanyl sodium) is indicated in the treatment of acute and chronic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of the upper and lower urinary tract and in <span class="product-label-link" type="condition" conceptid="4128402" conceptname="Asymptomatic bacteriuria">asymptomatic bacteriuria</span> due to susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following organisms:</p>
<p>  <span class="Italics">Escherichia coli</span><br>  <span class="Italics">Proteus mirabilis</span><br>  <span class="Italics">Morganella morganii </span>
(formerly <span class="Italics">Proteus morganii</span>)<br>  <span class="Italics">Providencia rettgeri</span>
 (formerly <span class="Italics">Proteus rettgeri</span>)<br>  <span class="Italics">Proteus vulgaris<br>  Pseudomonas<br>  Enterobacter<br>  Enterococci</span></p>
<p>Geocillin is also indicated in the treatment of <span class="product-label-link" type="condition" conceptid="194997" conceptname="Prostatitis">prostatitis</span> due to susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following organisms:</p>
<p><span class="Italics">  Escherichia coli</span><br>    Enterococcus (<span class="Italics">S. faecalis</span>)<br>  <span class="Italics">Proteus mirabilis</span><br>  <span class="Italics">Enterobacter</span>
 sp.</p>
<p>WHEN HIGH AND RAPID BLOOD AND URINE LEVELS OF ANTIBIOTIC ARE INDICATED, THERAPY WITH GEOPEN (CARBENICILLIN DISODIUM) SHOULD BE INITIATED BY PARENTERAL ADMINISTRATION FOLLOWED, AT THE PHYSICIAN'S DISCRETION, BY ORAL THERAPY.</p>
<p>NOTE: Susceptibility testing should be performed prior to and during the course of therapy to detect the possible emergence of resistant organisms which may develop.</p>
<p>To reduce the development of drug-resistant bacteria and maintain effectiveness of Geocillin and other antibacterial drugs, Geocillin should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-6"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Geocillin is ordinarily contraindicated in patients who have a known <span class="product-label-link" type="condition" conceptid="439224" conceptname="Drug allergy">penicillin allergy</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-7"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Serious and occasionally fatal <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> (anaphylactic) reactions have been reported in patients on oral penicillin therapy. Although <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> is more frequent following parenteral therapy, it has occurred in patients on oral penicillins. These reactions are more apt to occur in individuals with a history of penicillin <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> and/or a history of sensitivity to multiple allergens.</p>
<p>There have been reports of individuals with a history of penicillin <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> who have experienced severe <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> when treated with a cephalosporin, and vice versa. Before initiating therapy with a penicillin, careful inquiry should be made concerning previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> to penicillins, cephalosporins, or other allergens. If an <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span> occurs, the drug should be discontinued and the appropriate therapy instituted.</p>
<p>SERIOUS <span class="product-label-link" type="condition" conceptid="4148381" conceptname="Anaphylactoid reaction">ANAPHYLACTOID REACTIONS</span> REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE. OXYGEN, INTRAVENOUS STEROIDS AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED.</p>
<p><span class="Italics">Clostridium difficile</span> associated <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> (CDAD) has been reported with use of nearly all antibacterial agents, including GEOCILLIN(carbenicillin indanyl sodium ), and may range in severity from mild <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> to fatal <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of <span class="Italics">C. difficile</span>.</p>
<p><span class="Italics">C. difficile</span> produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics">C. difficile</span> cause increased morbidity and mortality, as these <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p>
<p>If CDAD is suspected or confirmed, ongoing antibiotic use not directed against <span class="Italics">C. difficile</span> may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of  <span class="Italics">C. difficile</span>, and surgical evaluation should be instituted as clinically indicated. </p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-8"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-8.1"></a><p></p>
<h2>General</h2>
<p class="First">As with any penicillin preparation, an allergic response, including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, may occur particularly in a hypersensitive individual.</p>
<p>Long term use of Geocillin may result in the overgrowth of nonsusceptible organisms. If <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occurs during therapy, appropriate measures should be taken.</p>
<p>Since carbenicillin is primarily excreted by the kidney, patients with severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (creatinine clearance of less than 10 ml/min) will not achieve therapeutic urine levels of carbenicillin.</p>
<p>In patients with creatinine clearance of 10–20 ml/min it may be necessary to adjust dosage to prevent accumulation of drug.</p>
<p>Prescribing Geocillin in the absence of proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> or a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-8.2"></a><p></p>
<h2>Information For Patients</h2>
<p class="First">Patients should be counseled that antibacterial drugs including Geocillin should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>. They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g., the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>). When Geocillin is prescribed to treat a <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Geocillin or other antibacterial drugs in the future.</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and <span class="product-label-link" type="condition" conceptid="443530" conceptname="Hematochezia">bloody stools</span> (with or without <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach cramps</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>) even as late as two or more months after having taken the last dose of the antibiotic.  If this occurs, patients should contact their physician as soon as possible.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-8.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">As with other penicillins, periodic assessment of organ system function including renal, hepatic, and hematopoietic systems is recommended during prolonged therapy.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-8.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Geocillin (carbenicillin indanyl sodium) blood levels may be increased and prolonged by concurrent administration of probenecid.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment Of Fertility</h2>
<p class="First">There are no long-term animal or human studies to evaluate carcinogenic potential. Rats fed 250–1000 mg/kg/day for 18 months developed mild liver pathology (e.g., bile duct <span class="product-label-link" type="condition" conceptid="4296894" conceptname="Hyperplasia">hyperplasia</span>) at all dose levels, but there was no evidence of drug-related neoplasia. Geocillin administered at daily doses ranging to 1000 mg/kg had no apparent effect on the fertility or reproductive performance of rats.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8.6"></a><p></p>
<h2>Pregnancy Category B</h2>
<p class="First">Reproduction studies have been performed at dose levels of 1000 or 500 mg/kg in rats, 200 mg/kg in mice, and at 500 mg/kg in monkeys with no harm to fetus due to Geocillin. There are, however, no adequate and well controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="section-8.7"></a><p></p>
<h2>Labor And Delivery</h2>
<p class="First">It is not known whether the use of Geocillin in humans during labor or delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of the newborn will be necessary.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-8.8"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Carbenicillin class antibiotics are excreted in milk although the amounts excreted are unknown; therefore, caution should be exercised if administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-8.9"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Since only limited clinical data is available to date in children, the safety of Geocillin administration in this age group has not yet been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-9"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The following adverse reactions have been reported as possibly related to Geocillin administration in controlled studies which include 344 patients receiving Geocillin.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.1"></a><p></p>
<h2>Gastrointestinal</h2>
<p class="First">The most frequent adverse reactions associated with Geocillin therapy are related to the gastrointestinal tract. <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, bad taste, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">flatulence</span>, and <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span> were reported. <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal cramps</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, furry tongue, <span class="product-label-link" type="condition" conceptid="197925" conceptname="Hemorrhage of rectum and anus">rectal bleeding</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, and unspecified <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span> were rarely reported.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.2"></a><p></p>
<h2>Dermatologic</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span> such as <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, and less frequently <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.3"></a><p></p>
<h2>Hematologic</h2>
<p class="First">As with other penicillins, <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>, <span class="product-label-link" type="condition" conceptid="320073" conceptname="Neutropenia">neutropenia</span>, and <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> have infrequently been observed. The clinical significance of these abnormalities is not known.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.4"></a><p></p>
<h2>Miscellaneous</h2>
<p class="First">Other reactions rarely reported were <span class="product-label-link" type="condition" conceptid="4178904" conceptname="Body temperature above reference range">hyperthermia</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4254270" conceptname="Itching of eye">itchy eyes</span>, <span class="product-label-link" type="condition" conceptid="4081648" conceptname="Acute vaginitis">vaginitis</span>, and <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">loose stools</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.5"></a><p></p>
<h2>Abnormalities of Hepatic Function Tests</h2>
<p class="First">Mild <span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span> elevations have been observed following Geocillin administration.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-10"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Geocillin is generally nontoxic. Geocillin when taken in excessive amounts may produce mild <span class="product-label-link" type="condition" conceptid="4318531" conceptname="Gastrointestinal irritation">gastrointestinal irritation</span>. The drug is rapidly excreted in the urine and symptoms are transitory. The usual symptoms of <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> may occur in hypersensitive individuals.</p>
<p>Carbenicillin blood levels achievable with Geocillin are very low, and toxic reactions as a function of overdosage should not occur systematically. The oral LD<span class="Sub">50</span>
 in mice is 3,600 mg/kg, in rats 2,000 mg/kg, and in dogs is in excess of 500 mg/kg. The lethal human dose is not known.</p>
<p>Although never reported, the possibility of accumulation of indanyl should be considered when large amounts of Geocillin are ingested. Free indole, which is a phenol derivative, may be potentially toxic. In general 8–15 grams of phenol, and presumably a similar amount of indole, are required orally before toxicity (peripheral <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">vascular collapse</span>) may occur. The metabolic by products of indole are nontoxic. In patients with <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic failure</span> it may be possible for unmetabolized indole to accumulate.</p>
<p>The metabolic by-products of Geocillin, indanyl sulfate and glucuronide, as well as free carbenicillin, are dialyzable.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-11"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Geocillin is available as a coated tablet to be administered orally.</p>
<table width="50%">
<caption><span>Usual Adult Dose</span></caption>
<col align="left">
<col align="left">
<tbody class="Headless">
<tr class="First">
<td class="Lrule" align="left"><span class="Italics"><span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">URINARY TRACT INFECTIONS</span></span></td>
<td class="Rrule" align="left"></td>
</tr>
<tr>
<td class="Lrule" align="left">  <span class="Italics">Escherichia coli, Proteus</span>
 species,<br>    and <span class="Italics">Enterobacter</span>
</td>
<td class="Rrule" align="left">1–2 tablets<br>
4 times daily</td>
</tr>
<tr>
<td class="Lrule" align="left">  <span class="Italics">Pseudomonas</span>
 and <span class="Italics">Enterococcus</span>
</td>
<td class="Rrule" align="left">2 tablets<br>
4 times daily</td>
</tr>
<tr>
<td class="Lrule" align="left"><span class="Italics"><span class="product-label-link" type="condition" conceptid="194997" conceptname="Prostatitis">PROSTATITIS</span></span></td>
<td class="Rrule" align="left"></td>
</tr>
<tr class="Last">
<td class="Lrule" align="left">  <span class="Italics">Escherichia coli, Proteus mirabilis,<br>    Enterobacter</span>
 and <span class="Italics">Enterococcus</span>
</td>
<td class="Rrule" align="left">2 tablets<br>
4 times daily</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-12"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Geocillin is available as film-coated tablets in bottles of 100's (NDC-0049-1430-66). Each tablet contains carbenicillin indanyl sodium equivalent to 382 mg of carbenicillin.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-13"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx only</span></p>
<div class="Figure"><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=02010995-9826-4A67-945B-F3022E6081DF&amp;name=geocillin-image02.jpg"></div>
<p>LAB-0031-5.0</p>
<p>May 2007</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>GEOCILLIN 		
					</strong><br><span class="contentTableReg">carbenicillin indanyl sodium tablet, film coated</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0049-1430</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>carbenicillin indanyl sodium</strong> (Carbenicillin) </td>
<td class="formItem"></td>
<td class="formItem">382 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>glycine</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>magnesium stearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium lauryl sulfate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>hydroxypropyl cellulose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>hypromellose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>opaspray</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Blue 2 Lake</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Yellow 6 Lake</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Yellow 10 Lake</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>opadry light yellow</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C Yellow 10 Lake</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C Yellow 6 Lake</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>opadry clear</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">YELLOW (YELLOW) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">OVAL (OVAL) </td>
<td class="formLabel">Size</td>
<td class="formItem">19mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">Roerig;143</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Coating</td>
<td class="formItem">true</td>
<td class="formLabel">Symbol</td>
<td class="formItem">false</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0049-1430-66</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Roerig</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 8/2007<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>21EC239F-B6F2-33B2-8CCD-24818A929BD8</div>
<div>Set id: 02010995-9826-4A67-945B-F3022E6081DF</div>
<div>Version: 2</div>
<div>Effective Time: 20070820</div>
</div>
</div> <div class="DistributorName">Roerig</div></p>
</body></html>
